TrialEuropean journal of nuclear medicine and molecular imaging2011

Phase II study of radiopeptide 177Lu-octreotate and capecitabine therapy of progressive disseminated neuroendocrine tumours.

Phillip G Claringbold et al.PubMed ↗Publisher ↗

No numbers read from the abstract.